BSE filing, BSE: 542477. Summary written from the filing by ALFA Finder's alert engine.
Glaam Up Jwel Ltd: key numbers
- Share price
- ₹18.87
- Market cap
- ₹18.90 Cr
- Revenue (annual)
- ₹12.39 Cr
- Net profit (annual)
- ₹0.12 Cr
- P/E (TTM)
- 159.2×Sector 43.1×
- Promoter holding
- 27.69%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Glaam Up Jwel Ltd
All →Glaam Up Jwel Board Meeting Date
Glaam Up Jwel Limited scheduled a board meeting for May 30, 2026. Directors will consider and approve standalone audited financial results for the fiscal year.
Glaam Up Jwel Other Announcement
Glaam Up Jwel Limited (formerly Gleam Fabmat Limited) notified BSE regarding the non-applicability of the Annual Secretarial Compliance Report for the year ended March 31, 2026. The company is exempt under SEBI Regulation 15(2) as an SME-listed entity. This is a standard regulatory disclosure and does not impact financial performance.
Glaam Up Jwel Debt & Borrowing
Glaam Up Jwel Limited informed BSE that it does not meet the criteria for 'Large Entities' as defined by SEBI circulars. Consequently, the mandatory incremental borrowing requirements for large corporates do not apply to the company for the current period.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.